📖 Oral and Maxillofacial Surgery
Coagulation Tests: PT and PTT
Oral and Maxillofacial SurgeryCoagulation Tests: PT and PTT
Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) are laboratory tests used to evaluate the coagulation pathways involved in blood clotting. Understanding these tests is crucial for diagnosing bleeding disorders and managing patients with specific factor deficiencies.
Prothrombin Time (PT)
- Purpose: PT is primarily used to assess the extrinsic pathway of coagulation.
- Factors Tested: It evaluates the function of factors I (fibrinogen), II (prothrombin), V, VII, and X.
- Clinical Use: PT is commonly used to monitor patients on anticoagulant therapy (e.g., warfarin) and to assess bleeding risk before surgical procedures.
Partial Thromboplastin Time (PTT)
- Purpose: PTT is used to assess the intrinsic pathway of coagulation.
- Factors Tested: It evaluates the function of factors I (fibrinogen), II (prothrombin), V, VIII, IX, X, XI, and XII.
- Clinical Use: PTT is often used to monitor patients on heparin therapy and to evaluate bleeding disorders.
Specific Factor Deficiencies
In certain bleeding disorders, specific factor deficiencies can lead to increased bleeding risk. Preoperative management may involve the administration of the respective clotting factors or antifibrinolytic agents to minimize bleeding during surgical procedures.
-
Hemophilia A:
- Deficiency: Factor VIII deficiency.
- Management: Administration of factor VIII concentrate before surgery.
-
Hemophilia B:
- Deficiency: Factor IX deficiency.
- Management: Administration of factor IX concentrate before surgery.
-
Hemophilia C:
- Deficiency: Factor XI deficiency.
- Management: Administration of factor XI concentrate or fresh frozen plasma (FFP) may be considered.
-
Von Willebrand’s Disease:
- Deficiency: Deficiency or dysfunction of von Willebrand factor (vWF), which is important for platelet adhesion.
- Management: Desmopressin (DDAVP) may be administered to increase vWF levels, or factor replacement therapy may be used.
-
Antifibrinolytic Agent:
- Aminocaproic Acid: This antifibrinolytic agent can be used to help stabilize clots and reduce bleeding during surgical procedures, particularly in patients with bleeding disorders.
Fascial Spaces & Trauma
Oral and Maxillofacial Surgery- Lateral pharyngeal space: Divided by styloid process into anterior/posterior compartments.
- Pterygomandibular space roof: Lateral pterygoid.
- Sublingual space: Contains deep part of submandibular gland.
- FAST exam: Ultrasound for trauma; checks perihepatic, perisplenic, pericardium, pelvis.
- Burn resuscitation fluid: Lactated Ringer’s solution.
Sjögren's Syndrome and Sialography
Oral and Maxillofacial SurgerySjögren's Syndrome and Sialography
Sjögren's syndrome is an autoimmune disorder characterized by the destruction of exocrine glands, particularly the salivary and lacrimal glands, leading to dry mouth (xerostomia) and dry eyes (keratoconjunctivitis sicca). One of the diagnostic tools used to evaluate the salivary glands in patients with Sjögren's syndrome is sialography.
Sialography Findings in Sjögren's Syndrome
-
Sialectasis: In sialography, Sjögren's syndrome is often associated with sialectasis, which refers to the dilation of the salivary gland ducts. This occurs due to the inflammatory changes and damage to the ductal system.
-
"Cherry Blossom" Appearance: The sialographic findings in Sjögren's syndrome can produce a characteristic appearance described as:
- "Cherry Blossom" or "Branchless Fruit Laden Tree": This appearance is due to the presence of many large dye-filled spaces within the salivary glands. The pattern resembles the branches of a tree laden with fruit, where the dye fills the dilated ducts and spaces, creating a striking visual effect.
-
Mechanism: The appearance is thought to result from the dye passing through weakened or damaged salivary gland ducts, which are unable to properly transport saliva due to the underlying pathology of the syndrome. The inflammation and fibrosis associated with Sjögren's syndrome lead to ductal obstruction and dilation.
Clinical Significance
-
Diagnosis: The characteristic sialographic appearance can aid in the diagnosis of Sjögren's syndrome, especially when combined with clinical findings and other diagnostic tests (e.g., labial salivary gland biopsy).
-
Management: Understanding the changes in the salivary glands can help guide management strategies for patients, including the use of saliva substitutes, medications to stimulate saliva production, and regular dental care to prevent complications associated with dry mouth.
Nerve Supply & Muscles
Oral and Maxillofacial Surgery| Structure | Nerve Supply |
|---|---|
| Tensor tympani & veli palatini | Nerve to medial pterygoid |
| Stapedius, buccinator, digastric (post) | Facial nerve |
| Tongue (ant 2/3) | Chorda tympani + lingual nerve |
| Tongue (post 1/3) | Glossopharyngeal |
| Tongue (posterior – most) | Internal laryngeal (vagus) |
| SCM | Spinal accessory (motor) + C2, C3 (proprioception) |
| Facial muscles | Facial nerve (except levator palpebrae: oculomotor) |
| Tongue muscles | Hypoglossal (except palatoglossus: cranial accessory via pharyngeal plexus) |
| Larynx muscles | Recurrent laryngeal (except cricothyroid: external laryngeal) |
